#TrialChat

Creative solutions to drive clinical research participation

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/undefined undefined)
(Image: Getty/undefined undefined)
Addressing seemingly small challenges can make all the difference for patients, many of whom are still largely unaware of clinical trials.

This week we partnered with ACRP, Greater Gift, and PopUp Star to discuss how the industry is addressing “patient centricity” – and where it is falling short.

What are the main challenges to clinical trial participation and what are the challenges of tomorrow? What is being done at a community-level to raise awareness and promote change?

See below for a wrap up of the discussion and continue the conversation on Twitter​ using the hashtag #TrialChat​.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars